0001209191-20-031063.txt : 20200520
0001209191-20-031063.hdr.sgml : 20200520
20200520200755
ACCESSION NUMBER: 0001209191-20-031063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200518
FILED AS OF DATE: 20200520
DATE AS OF CHANGE: 20200520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BORKAR RATAN S
CENTRAL INDEX KEY: 0001720077
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 20899638
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-18
0
0000353569
QUIDEL CORP /DE/
QDEL
0001720077
BORKAR RATAN S
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
SVP, Intl Comm Operations
Common Stock
2020-05-18
4
S
0
1665
196.7752
D
10839
D
Common Stock
2020-05-18
4
M
0
1898
21.08
A
12737
D
Common Stock
2020-05-18
4
M
0
4606
46.41
A
17343
D
Common Stock
2020-05-18
4
M
0
5376
15.40
A
22719
D
Common Stock
2020-05-18
4
M
0
4452
41.36
A
27171
D
Common Stock
2020-05-18
4
S
0
16332
192.5277
D
10839
D
Common Stock
2020-05-18
4
S
0
10315
192.6437
D
524
D
Non-Qualified Stock Option
21.08
2020-05-18
4
M
0
1898
0.00
D
2027-02-15
Common Stock
1898
1898
D
Non-Qualified Stock Option
46.41
2020-05-18
4
M
0
4606
0.00
D
2028-01-16
Common Stock
4606
4606
D
Non-Qualified Stock Option
15.40
2020-05-18
4
M
0
5376
0.00
D
2026-02-10
Common Stock
5376
0
D
Non-Qualified Stock Option
41.36
2020-05-18
4
M
0
4452
0.00
D
2027-10-16
Common Stock
4452
4450
D
The weighted average sale price for these transactions was $196.7752 per share, with a range of $191.95 to $201.10. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $192.5277 per share, with a range of $185.17 to $201.10. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $192.6437 per share, with a range of $185.17 to $201.10. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
3,797 shares vested on the second anniversary of the grant date, February 15, 2019. 1,898 shares vested on the third anniversary date of the grant date, February 15, 2020. 1,898 shares will vest on the fourth anniversary date of the grant date, February 15, 2021.
4606 shares vested on the second anniversary of the grant date, January 16, 2020. 2,303 shares will vest on the third anniversary date of the grant date, January 16, 2021. 2,303 shares will vest on the fourth anniversary date of the grant date, January 16, 2022.
10,754 shares vested on the second anniversary date of the grant date, February 10, 2018. 5,376 shares vested on the third anniversary date of the grant date, February 10, 2019. 5,376 shares vested on the fourth anniversary date of the grant date, February 10, 2020.
4,452 shares vested on the second anniversary date of the grant date, October 16, 2019. 2,225 shares will vest on the third anniversary date of the grant date, October 16, 2020. 2,225 shares will vest on the fourth anniversary date of the grant date, October 16, 2021.
All transactions reported herein were effected pursuant to a pre-established 10b5-1 trading plan.
Robert J. Bujarski, attorney-in-fact for Ratan S. Borkar
2020-05-20